An impurity of Felypressin. Felypressin is a Vasopressin 1 agonist, and will thus have effects at all Arginine vasopressin receptor 1As. It physiologically effects on vascular SMC's due to the form in which it is administered. Its receptors are found in various sites around the body. The major points include the CNS, Liver, Anterior Pituitary, Muscle (both vascular and non-vascular smooth muscle), and Platelets (CLAMP).
CAT No: 10-101-189
Felypressin Impurity B is a specialized carbohydrate-related compound recognized for its significance in pharmaceutical research and chemical analysis. As an impurity associated with the synthetic peptide felypressin, this molecule offers unique structural features that make it invaluable for advanced analytical studies. Its distinct chemical identity enables researchers to evaluate the composition and stability of peptide-based formulations, supporting the development of robust quality control protocols. With its defined structure, Felypressin Impurity B is frequently employed in a variety of scientific investigations, providing a reliable reference for impurity profiling and method validation in peptide synthesis.
Analytical Reference Standard: In pharmaceutical and chemical laboratories, Felypressin Impurity B is widely utilized as an analytical reference standard. By incorporating this impurity into chromatographic or spectrometric assays, scientists can accurately identify and quantify trace levels of related substances within felypressin preparations. The presence of a well-characterized impurity standard is essential for establishing the specificity and sensitivity of analytical methods, thus ensuring the reliability of impurity detection and quantification in complex matrices.
Method Development and Validation: During the development and validation of analytical methods for peptide drugs, the inclusion of Felypressin Impurity B serves as a critical tool for assessing method performance. Researchers employ it to challenge the selectivity and robustness of separation techniques such as HPLC or LC-MS. By monitoring the response and resolution of this impurity, method developers can optimize parameters to achieve precise discrimination between the active pharmaceutical ingredient and its related substances, thereby enhancing the overall accuracy and reproducibility of analytical protocols.
Degradation Pathway Elucidation: The study of degradation pathways in peptide pharmaceuticals often necessitates the identification and characterization of potential impurities. Felypressin Impurity B plays a pivotal role in such investigations by acting as a model compound for understanding the chemical transformations that may occur during storage or processing. By tracking its formation and behavior under various stress conditions, researchers can gain valuable insights into the stability profile of felypressin and related peptides, ultimately informing formulation strategies and shelf-life assessments.
Process Development and Optimization: In the context of synthetic process development, the presence and control of impurities such as Felypressin Impurity B are of paramount importance. Chemists utilize this compound to monitor the efficiency and selectivity of peptide synthesis routes, enabling them to refine reaction conditions and purification procedures. The systematic evaluation of impurity levels throughout the manufacturing process supports the achievement of high product quality and consistency, which is crucial for research and development initiatives.
Peptide Impurity Profiling: Comprehensive profiling of peptide impurities is essential for understanding the chemical landscape of pharmaceutical preparations. Felypressin Impurity B is frequently incorporated into impurity profiling studies to establish reference retention times, mass spectra, and other analytical signatures. This information facilitates the identification of unknown peaks during routine batch analysis and supports the creation of impurity libraries for ongoing quality assurance efforts.
Pharmaceutical research, analytical chemistry, process development, peptide impurity profiling, and degradation studies all benefit from the inclusion of Felypressin Impurity B in their workflows. Its unique characteristics as a structurally defined impurity standard enable scientists to advance their understanding of peptide-related impurities, optimize analytical and manufacturing processes, and ensure the integrity of peptide-based products. As research in peptide therapeutics and peptide chemistry continues to expand, the role of such impurity standards remains integral to the advancement of high-quality, reproducible scientific outcomes.
3. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die
4. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
5. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More